Endoscopic Mucosal Resection: Indications and Contraindications
Primary Indication
EMR is the preferred treatment for large (≥20 mm) non-pedunculated colorectal lesions, as it provides complete resection while avoiding the higher morbidity, mortality, and cost of surgical alternatives. 1
Specific Indications by Lesion Size
Large Lesions (≥20 mm)
- EMR is strongly recommended as first-line therapy for all non-pedunculated colorectal lesions ≥20 mm in diameter 1
- These procedures must be performed by endoscopists experienced in advanced polypectomy 1
- The technique achieves low severe adverse event rates (1%) and acceptable recurrence rates (14%) based on systematic review of 6,442 patients 1
Medium Lesions (10-19 mm)
- Cold or hot snare polypectomy (with or without submucosal injection) is suggested for 10-19 mm non-pedunculated lesions 1
- However, EMR should be specifically considered for non-polypoid and serrated lesions in this size range, as conventional polypectomy shows 31% incomplete resection rates for these morphologies 1
- Proximal serrated lesions averaging 15.9 mm removed by EMR demonstrate only 3.6% recurrence rates versus much higher rates with conventional techniques 1
Small and Diminutive Lesions
- Cold snare polypectomy is recommended for lesions 5-9 mm 1, 2
- EMR is not indicated for these smaller lesions 1
Indications by Lesion Morphology
High-Risk Morphologic Features Requiring Advanced Technique
- Paris classification 0-IIa+c morphology (elevated with central depression) 3
- Non-granular lateral spreading tumors (LST-NG), particularly with sessile shape or depression 4
- Granular LSTs with dominant nodule 4
- Lesions with Kudo pit pattern type V 3
Standard EMR-Appropriate Morphology
- Paris 0-IIa granular lesions have low submucosal invasion rates (1.4%) and are ideal for EMR 3
- Granular lateral spreading tumors without dominant nodules 4
Specific Clinical Scenarios
When EMR is Preferred Over ESD
- Mucosal or submucosal adenomas >20 mm where piecemeal resection is acceptable (EMR is Grade I recommendation, ESD is Grade II) 4
- Flat lesions 5-20 mm without fibrosis or suspected invasion (EMR is Grade I, ESD is Grade II) 4
- Sessile lesions >10 mm suspected to be villous adenomas or sessile serrated adenomas/polyps (EMR is Grade I, ESD is Grade II) 4
When to Consider ESD Instead of EMR
- Lateral spreading tumors ≥20 mm where en bloc resection is required 4
- Villous adenomas ≥25 mm (ESD is Grade I for these specific lesions) 4
- Lesions suspected to have submucosal invasion 1, 4
- Mucosal lesions with fibrosis 1, 4
- Local residual early carcinoma after prior endoscopic resection 1, 4
- Non-polypoid colorectal dysplasia in inflammatory bowel disease patients 1, 4
Absolute Contraindications
Deep Submucosal Invasion
- NICE 3 classification features (disrupted surface pattern, absent vessels, or dark brown color) predict deep submucosal invasion with 94% accuracy 4
- Kudo pit pattern type VN has 90.4% sensitivity and 88.4% specificity for invasive cancer 4
- JNET Type 3 features (loose vessel areas with interruption of thick vessels, amorphous surface areas) indicate deep submucosal invasive cancer 5
- When these features are present in non-pedunculated lesions, perform limited cold forceps biopsy only in the area of surface disruption, tattoo the site, and refer directly to colorectal surgery 5
Technical Contraindications
- Prior failed EMR attempts are associated with significantly higher risk of incomplete resection or recurrence (OR 3.8) 1, 3
- Ileocecal valve involvement increases risk of EMR failure (OR 3.4) 3
Relative Contraindications and High-Risk Scenarios
Anticoagulation
- Patients on antithrombotics require individualized assessment balancing interruption risks against bleeding risks for lesions ≥20 mm 1
Lesion Location
- Right colon lesions ≥20 mm require prophylactic clip closure of the resection defect to reduce delayed bleeding risk 1, 2
Lesion Size
- Lesions >40 mm have significantly higher recurrence rates (OR 4.37) after EMR 3
- For these very large lesions, consider ESD if en bloc resection is critical 4
Critical Technical Requirements
Resection Technique
- All grossly visible tissue must be resected in a single colonoscopy session and in the safest minimum number of pieces 1
- En bloc resection is preferred when feasible for lesions <20 mm 1
- Piecemeal resection is acceptable for lesions ≥20 mm when performed correctly 1
Injection Solutions
- Viscous injection solutions (hydroxyethyl starch, Eleview, ORISE Gel) are suggested for lesions ≥20 mm to enable fewer pieces and less procedure time 1
- Contrast agents (indigo carmine or methylene blue) should be used to facilitate recognition of tissue layers 1
- Carbon particle suspension (tattoo) must NOT be used as submucosal injection solution, as it causes submucosal fibrosis and reduces future resection success 1
Margin Treatment
- Ablative techniques (APC, snare tip soft coagulation) are contraindicated on endoscopically visible residual tissue, as they increase recurrence risk 1
- Adjuvant thermal ablation of the post-EMR margin is suggested only where no endoscopically visible adenoma remains after meticulous inspection 1, 4, 2
Gastric EMR Indications
Early Gastric Cancer
- EMR is indicated for Tis or T1a tumors (limited to mucosa) 6
- Specific criteria required: well- or moderately differentiated histology, tumors <30 mm, absence of ulceration, no evidence of invasive findings 6
- Node-negative T1 tumors have >90% 5-year survival with limited resection 6
- Routine use outside clinical trials is not recommended and should be limited to medical centers with extensive experience 6
Risk Factors Increasing Lymph Node Metastasis Probability
- Increasing tumor size 6
- Submucosal invasion 6
- Poorly differentiated tumors 6
- Lymphatic and vascular invasion 6
Post-EMR Management
Surveillance Requirements
- Surveillance colonoscopy is mandatory regardless of EMR technique due to risk of residual or recurrent polyp formation 7
- Highest risk patients for recurrence: lesions >40 mm and those treated with argon plasma coagulation 3